These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


104 related items for PubMed ID: 12397884

  • 21. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
    Malhi GS, Ng F, Berk M.
    Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
    [Abstract] [Full Text] [Related]

  • 22. Patient preferences for depression treatment programs and willingness to pay for treatment.
    Morey E, Thacher JA, Craighead WE.
    J Ment Health Policy Econ; 2007 Jun; 10(2):73-85. PubMed ID: 17603148
    [Abstract] [Full Text] [Related]

  • 23. Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms.
    Bschor T, Lewitzka U, Sasse J, Adli M, Köberle U, Bauer M.
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S230-4. PubMed ID: 14677084
    [Abstract] [Full Text] [Related]

  • 24. Combined antidepressants: clinical experience.
    Rojo JE, Ros S, Agüera L, de la Gándara J, de Pedro JM.
    Acta Psychiatr Scand Suppl; 2005 Nov; (428):25-31, 36. PubMed ID: 16307617
    [Abstract] [Full Text] [Related]

  • 25. A survey of prescribing practices in the treatment of depression.
    Petersen T, Dording C, Neault NB, Kornbluh R, Alpert JE, Nierenberg AA, Rosenbaum JF, Fava M.
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jan; 26(1):177-87. PubMed ID: 11853110
    [Abstract] [Full Text] [Related]

  • 26. Use of atypical antipsychotics in refractory depression and anxiety.
    Nemeroff CB.
    J Clin Psychiatry; 2005 Jan; 66 Suppl 8():13-21. PubMed ID: 16336032
    [Abstract] [Full Text] [Related]

  • 27. [Therapy resistance to antidepressive drugs: risk factors and treatment possibilities].
    Möller HJ.
    Nervenarzt; 1991 Nov; 62(11):658-69. PubMed ID: 1770965
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [How to treat and manage unsatisfactory response?].
    El-Hage W, Fakra E.
    Encephale; 2016 Feb; 42(1 Suppl 1):1S39-47. PubMed ID: 26879256
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: a survey of clinicians.
    Mischoulon D, Nierenberg AA, Kizilbash L, Rosenbaum JF, Fava M.
    Can J Psychiatry; 2000 Jun; 45(5):476-81. PubMed ID: 10900529
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Management of treatment-resistant depression without ECT (author's transl)].
    Kielholz P, Terzani S, Gastpar M, Adams C.
    Dtsch Med Wochenschr; 1981 May 22; 106(21):671-3. PubMed ID: 6113126
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.